MwanzoINDV • LON
add
Indivior PLC
Bei iliyotangulia
GBX 851.00
Bei za siku
GBX 854.00 - GBX 898.00
Bei za mwaka
GBX 548.71 - GBX 1,486.00
Thamani ya kampuni katika soko
1.11B GBP
Wastani wa hisa zilizouzwa
elfu 324.62
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
LON
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 266.00M | -6.34% |
Matumizi ya uendeshaji wa biashara | 152.00M | -12.14% |
Mapato halisi | 47.00M | 0.00% |
Kiwango cha faida halisi | 17.67 | 6.77% |
Mapato kwa kila hisa | 0.41 | 10.81% |
EBITDA | 75.00M | 4.17% |
Asilimia ya kodi ya mapato | 18.97% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 373.00M | 13.03% |
Jumla ya mali | 1.38B | -5.37% |
Jumla ya dhima | 1.66B | 15.04% |
Jumla ya hisa | -285.00M | — |
hisa zilizosalia | 125.00M | — |
Uwiano wa bei na thamani | -3.73 | — |
Faida inayotokana na mali | 12.32% | — |
Faida inayotokana mtaji | 137.80% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 47.00M | 0.00% |
Pesa kutokana na shughuli | 75.00M | 236.36% |
Pesa kutokana na uwekezaji | -5.00M | -120.00% |
Pesa kutokana na ufadhili | -17.00M | 55.26% |
Mabadiliko halisi ya pesa taslimu | 53.00M | 177.94% |
Mtiririko huru wa pesa | 101.25M | 1,180.00% |
Kuhusu
Indivior is a specialty pharmaceuticals business. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, the company has been fined for false marketing claims about the safety of its drug, Suboxone. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
26 Sep 2014
Tovuti
Wafanyakazi
1,000
